The deal is expected to expand Roche's molecular diagnostics portfolio, its CEO said. Bloomberg
The deal is expected to expand Roche's molecular diagnostics portfolio, its CEO said. Bloomberg
Roche strikes deal to buy Covid test maker GenMark for $1.8bn
GenMark’s tests can detect multiple pathogens from a single patient sample
